Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Mary Rusckowski

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Concepts & Ideas

Tissue Distribution

Chemicals & Drugs

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Liu Guozheng; Dou Shuping; Liang Minmin; Chen Xiangji; Rusckowski Mary; Hnatowich Donald J
The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size.
Liang Minmin; Liu Xinrong; Nakamura Kayoko; Chen Xiangji; Cheng Dengfeng; Liu Guozheng; Dou Shuping; Wang Yi; Rusckowski Mary; Hnatowich Donald J
A convenient thiazole orange fluorescence assay for the evaluation of DNA duplex hybridization stability.
Wang Yi; Liu Xinrong; Nakamura Kayoko; Chen Ling; Rusckowski Mary; Hnatowich Donald J
In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mary Rusckowski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Liu Guozheng; Dou Shuping; Liang Minmin; Chen Xiangji; Rusckowski Mary; Hnatowich Donald J
The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size.
European journal of cancer (Oxford, England : 1990) 2009;45(17):3098-103.
2009: Liang Minmin; Liu Xinrong; Nakamura Kayoko; Chen Xiangji; Cheng Dengfeng; Liu Guozheng; Dou Shuping; Wang Yi; Rusckowski Mary; Hnatowich Donald J
A convenient thiazole orange fluorescence assay for the evaluation of DNA duplex hybridization stability.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(6):439-45.
2009: Wang Yi; Liu Xinrong; Nakamura Kayoko; Chen Ling; Rusckowski Mary; Hnatowich Donald J
In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles.
Cancer biotherapy & radiopharmaceuticals 2009;24(5):573-8.
2009: Liu Guozheng; Cheng Dengfeng; Dou Shuping; Chen Xiangji; Liang Minmin; Pretorius P Hendrik; Rusckowski Mary; Hnatowich Donald J
Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(5):303-7.
2009: Liang Minmin; Liu Xinrong; Cheng Dengfeng; Nakamura Kayoko; Wang Yi; Dou Shuping; Liu Guozheng; Rusckowski Mary; Hnatowich Donald J
Optical antisense tumor targeting in vivo with an improved fluorescent DNA duplex probe.
Bioconjugate chemistry 2009;20(6):1223-7.
2009: Liu Xinrong; Wang Yi; Nakamura Kayoko; Kawauchi Sumi; Akalin Ali; Cheng Dengfeng; Chen Ling; Rusckowski Mary; Hnatowich Donald J
Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(4):582-90.
2008: Chen Ling; Wang Yi; Liu Xinrong; Dou Shuping; Liu Guozheng; Hnatowich Donald J; Rusckowski Mary
A new TAG-72 cancer marker peptide identified by phage display.
Cancer letters 2008;272(1):122-32.
2008: Chen Xiangji; Dou Shuping; Liu Guozheng; Liu Xinrong; Wang Yi; Chen Ling; Rusckowski Mary; Hnatowich Donald J
Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.
Bioconjugate chemistry 2008;19(8):1518-25.
2008: Liu Guozheng; Dou Shuping; Rusckowski Mary; Hnatowich Donald J
An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector.
Molecular cancer therapeutics 2008;7(5):1025-32.
2008: Rusckowski Mary; Gupta Suresh; Liu Guozheng; Dou Shuping; Hnatowich Donald J
Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imaging.
Nuclear medicine and biology 2008;35(4):433-40.
2008: Kleine Lauren G; Solano Mauricio; Rusckowski Mary; Hunt Kathleen E; Johnson Karen L; Kirker-Head Carl A
Evaluation of technetium Tc 99m-labeled biotin for scintigraphic detection of soft tissue inflammation in horses.
American journal of veterinary research 2008;69(5):639-46.
2008: Liu Guozheng; Dou Shuping; Pretorius P Hendrik; Liu Xinrong; Rusckowski Mary; Hnatowich Donald J
Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.
European journal of nuclear medicine and molecular imaging 2008;35(2):272-80.
2007: Liu Xinrong; Wang Yi; Nakamura Kayoko; Liu Guozheng; Dou Shuping; Kubo Atsushi; Rusckowski Mary; Hnatowich Donald J
Optical antisense imaging of tumor with fluorescent DNA duplexes.
Bioconjugate chemistry 2007;18(6):1905-11.
2007: Rusckowski Mary; Gupta Suresh; Liu Guozheng; Dou Shuping; Hnatowich Donald J
Evidence of specificity of radiolabeled phage display peptides for the TAG-72 antigen.
Cancer biotherapy & radiopharmaceuticals 2007;22(4):564-72.
2007: Zhang Surong; Liu Guozheng; Liu Xinrong; Yin Dongguang; Dou Shuping; He Jiang; Rusckowski Mary; Hnatowich Donald J
Comparison of several linear fluorophore- and quencher-conjugated oligomer duplexes for stability, fluorescence quenching, and kinetics in vitro and in vivo in mice.
Bioconjugate chemistry 2007;18(4):1170-5.
2007: He Jiang; Liu Guozheng; Dou Shuping; Gupta Suresh; Rusckowski Mary; Hnatowich Donald
An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.
Bioconjugate chemistry 2007;18(3):983-8.
2007: Liu Guozheng; Dou Shuping; Yin Dongguang; Squires Shayne; Liu Xinrong; Wang Yi; Rusckowski Mary; Hnatowich Donald J
A novel pretargeting method for measuring antibody internalization in tumor cells.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):33-9.
2007: Liu Guozheng; Dou Shuping; He Jiang; Liu Xinrong; Rusckowski Mary; Hnatowich Donald J
Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
European journal of nuclear medicine and molecular imaging 2007;34(2):237-46.
2007: Wang Yi; Liu Xinrong; Zhang Yumin; Liu Guozheng; Rusckowski Mary; Hnatowich Donald J
Nonspecific cellular accumulation of 99mTc-labeled oligonucleotides in culture is influenced by their guanine content.
Nuclear medicine and biology 2007;34(1):47-54.
2007: He Jiang; Rusckowski Mary; Wang Yi; Dou Shuping; Liu Xinrong; Zhang Surong; Liu Guozheng; Hnatowich Donald J
Optical pretargeting of tumor with fluorescent MORF oligomers.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2007;9(1):17-23.
2006: Liu Xinrong; Nakamura Kayoko; Wang Yi; Zhang Surong; He Jiang; Liu Guozheng; Dou Shuping; Kubo Atsushi; Rusckowski Mary; Hnatowich Donald
Improved delivery in cell culture of radiolabeled antisense DNAs by duplex formation.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(5):278-83.
2006: Liu Guozheng; Dou Shuping; He Jiang; Yin Dongguang; Gupta Suresh; Zhang Surong; Wang Yi; Rusckowski Mary; Hnatowich Donald J
Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2006;64(9):971-8.
2006: Liu Guozheng; Dou Shuping; Mardirossian George; He Jiang; Zhang Surong; Liu Xinrong; Rusckowski Mary; Hnatowich Donald J
Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4958-64.
2006: Zhang Yu-Min; Tung Ching-Hsuan; He Jiang; Liu Ning; Yanachkov Ivan; Liu Guozheng; Rusckowski Mary; Vanderheyden Jean-Luc
Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics.
Nuclear medicine and biology 2006;33(2):263-9.
2006: Liu Xinrong; Nakamura Kayoko; Wang Yi; Wang Yee; Liu Guozheng; He Jiang; Ding Hongliu; Lu Peiyuan; Rusckowski Mary; Kubo Atsushi; Hnatowich Donald J
Initial mechanistic studies of antisense targeting in cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):360-8.
2005: Liu Guozheng; He Jiang; Dou Shuping; Gupta Suresh; Rusckowski Mary; Hnatowich Donald J
Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
European journal of nuclear medicine and molecular imaging 2005;32(9):1115-23.
2004: Zhang Yumin; He Jiang; Liu Guozheng; Venderheyden Jean-Luc; Gupta Suresh; Rusckowski Mary; Hnatowich Donald J
Initial observations of 99mTc labelled locked nucleic acids for antisense targeting.
Nuclear medicine communications 2004;25(11):1113-8.
2004: Nakamura K; Fan C; Liu G; Gupta S; He J; Dou S; Kubo A; Rusckowski M; Hnatowich D J
Evidence of antisense tumor targeting in mice.
Bioconjugate chemistry 2004;15(6):1475-80.
2004: Liu Guozheng; Dou Shuping; He Jiang; Vanderheyden Jean-Luc; Rusckowski Mary; Hnatowich Donald J
Preparation and properties of 99mTc(CO)3+-labeled N,N-bis(2-pyridylmethyl)-4-aminobutyric acid.
Bioconjugate chemistry 2004;15(6):1441-6.
2004: Rusckowski Mary; Gupta Suresh; Liu Guozheng; Dou Shuping; Hnatowich Donald J
Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1201-8.
2004: He Jiang; Liu Changbin; Vanderheyden Jean-Luc; Liu Guozheng; Dou Shuping; Rusckowski Mary; Hnatowich Donald J
Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
Nuclear medicine communications 2004;25(7):731-6.
2004: He Jiang; Liu Guozheng; Gupta Suresh; Zhang Yumin; Rusckowski Mary; Hnatowich Donald J
Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(6):1087-95.
2004: Liu Guozheng; He Jiang; Dou Shuping; Gupta Suresh; Vanderheyden Jean-Luc; Rusckowski Mary; Hnatowich Donald J
Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake.
European journal of nuclear medicine and molecular imaging 2004;31(3):417-24.
2003: He Jiang; Liu Guozheng; Zhang Surong; Rusckowski Mary; Hnatowich Donald J
Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting.
Cancer biotherapy & radiopharmaceuticals 2003;18(6):941-7.
2003: He Jiang; Liu Guozheng; Zhang Surong; Vanderheyden Jean-Luc; Liu Ning; Liu Changbin; Zhang Yumin; Gupta Suresh; Rusckowski Mary; Hnatowich Donald J
A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length.
Bioconjugate chemistry 2003;14(5):1018-23.
2003: Ferro-Flores Guillermina; Arteaga de Murphy Consuelo; Pedraza-López Martha; Meléndez-Alafort Laura; Zhang Yu-Min; Rusckowski Mary; Hnatowich Donald J
In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria.
Nuclear medicine and biology 2003;30(6):597-603.
2003: Zhang Yu-Min; Liu Chang-Bin; Liu Ning; Ferro Flores Guillermina; He Jiang; Rusckowski Mary; Hnatowich Donald J
Electrostatic binding with tat and other cationic peptides increases cell accumulation of 99mTc-antisense DNAs without entrapment.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2003;5(4):240-7.
2003: Liu G; Liu C; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich D J
Investigations of 99mTc morpholino pretargeting in mice.
Nuclear medicine communications 2003;24(6):697-705.
2003: Liu Chang-bin; Liu Guo-zheng; Liu Ning; Zhang Yu-min; He Jiang; Rusckowski Mary; Hnatowich Donald J
Radiolabeling morpholinos with 90Y, 111In, 188Re and 99mTc.
Nuclear medicine and biology 2003;30(2):207-14.
2003: Su Zi-Fen; He Jiang; Rusckowski Mary; Hnatowich Donald J
In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands.
Nuclear medicine and biology 2003;30(2):141-9.
2002: Liu Guozheng; He Jiang; Zhang Surong; Liu Changbin; Rusckowski Mary; Hnatowich Donald J
Cytosine residues influence kidney accumulations of 99mTc-labeled morpholino oligomers.
Antisense & nucleic acid drug development 2002;12(6):393-8.
2002: Liu G; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich D J
The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2002;46(3):233-43.
2002: Liu Guozheng; Zhang Surong; He Jiang; Zhu Zhihong; Rusckowski Mary; Hnatowich Donald J
Improving the labeling of S-acetyl NHS-MAG(3)-conjugated morpholino oligomers.
Bioconjugate chemistry 2002;13(4):893-7.
2002: Su Zi-Fen; Liu Guozheng; Gupta Suresh; Zhu Zhihong; Rusckowski Mary; Hnatowich Donald J
In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.
Bioconjugate chemistry 2002;13(3):561-70.
2002: Liu Guozheng; Mang'era Kennedy; Liu Ning; Gupta Suresh; Rusckowski Mary; Hnatowich Donald J
Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(3):384-91.
2002: Liu Guozheng; Wescott Charles; Sato Aaron; Wang Yi; Liu Ning; Zhang Yu-Min; Rusckowski Mary; Hnatowich Donald J
Nitriles form mixed-coligand complexes with (99m)Tc-HYNIC-peptide.
Nuclear medicine and biology 2002;29(1):107-13.
2001: Rusckowski M; Qu T; Gupta S; Ley A; Hnatowich D J
A comparison in monkeys of (99m)Tc labeled to a peptide by 4 methods.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(12):1870-7.
2001: Mang'era K O; Liu G; Yi W; Zhang Y; Liu N; Gupta S; Rusckowski M; Hnatowich D J
Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
European journal of nuclear medicine 2001;28(11):1682-9.
2001: Zhang Y M; Wang Y; Liu N; Zhu Z H; Rusckowski M; Hnatowich D J
In vitro investigations of tumor targeting with (99m)Tc-labeled antisense DNA.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(11):1660-9.
2001: Zhang Y M; Rusckowski M; Liu N; Liu C; Hnatowich D J
Cationic liposomes enhance cellular/nuclear localization of 99mTc-antisense oligonucleotides in target tumor cells.
Cancer biotherapy & radiopharmaceuticals 2001;16(5):411-9.
2001: Wang Y; Chang F; Zhang Y; Liu N; Liu G; Gupta S; Rusckowski M; Hnatowich D J
Pretargeting with amplification using polymeric peptide nucleic acid.
Bioconjugate chemistry 2001;12(5):807-16.
2001: Zhu Z; Wang Y; Zhang Y; Liu G; Liu N; Rusckowski M; Hnatowich D J
A novel and simplified route to the synthesis of N3S chelators for 99mTc labeling.
Nuclear medicine and biology 2001;28(6):703-8.
2001: Qu T; Wang Y; Zhu Z; Rusckowski M; Hnatowich D J
Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm.
Nuclear medicine communications 2001;22(2):203-15.
2000: Zhang Y M; Liu N; Zhu Z H; Rusckowski M; Hnatowich D J
Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA.
European journal of nuclear medicine 2000;27(11):1700-7.
2000: Rusckowski M; Qu T; Roskey A; Agrawal S
Biodistribution and metabolism of a mixed backbone oligonucleotide (GEM 231) following single and multiple dose administration in mice.
Antisense & nucleic acid drug development 2000;10(5):333-45.
2000: Rusckowski M; Qu T; Pullman J; Marcel R; Ley A C; Ladner R C; Hnatowich D J
Inflammation and infection imaging with a 99mTc-neutrophil elastase inhibitor in monkeys.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(2):363-74.
1999: Hnatowich D J; Chang F; Qu T; Rusckowski M
Technetium-99m labeled peptides--an investigation of multiple HPLC peaks.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1999;50(5):911-21.
1999: Chang F; Qu T; Rusckowski M; Hnatowich D J
NHS-MAS3: a bifunctional chelator alternative to NHS-MAG3.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1999;50(4):723-32.
1999: Fogarasi M; Pullman J; Winnard P; Hnatowich D J; Rusckowski M
Pretargeting of bacterial endocarditis in rats with streptavidin and 111In-labeled biotin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(3):484-90.
1998: Hnatowich D J; Qu T; Chang F; Ley A C; Ladner R C; Rusckowski M
Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(1):56-64.
1997: Rusckowski M; Qu T; Chang F; Hnatowich D J
Pretargeting using peptide nucleic acid.
Cancer 1997;80(12 Suppl):2699-705.
1997: Chang F; Rusckowski M; Qu T; Hnatowich D J
Early results in the irrational design of new bifunctional chelators.
Cancer 1997;80(12 Suppl):2347-53.
1997: Rusckowski M; Qu T; Chang F; Hnatowich D J
Technetium-99m labeled epidermal growth factor-tumor imaging in mice.
The journal of peptide research : official journal of the American Peptide Society 1997;50(5):393-401.
1997: Winnard P; Chang F; Rusckowski M; Mardirossian G; Hnatowich D J
Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.
Nuclear medicine and biology 1997;24(5):425-32.
1997: Mardirossian G; Lei K; Rusckowski M; Chang F; Qu T; Egholm M; Hnatowich D J
In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):907-13.
1997: Hnatowich D J; Chang F; Lei K; Qu T; Rusckowski M
The influence of temperature and alkaline pH on the labeling of free and conjugated MAG3 with technetium-99m.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1997;48(5):587-94.
1997: Rusckowski M; Fogarasi M; Fritz B; Hnatowich D J
Effect of endogenous biotin on the applications of streptavidin and biotin in mice.
Nuclear medicine and biology 1997;24(3):263-8.
1996: Lei K; Rusckowski M; Chang F; Qu T; Mardirossian G; Hnatowich D J
Technetium-99m antibodies labeled with MAG3 and SHNH: an in vitro and animal in vivo comparison.
Nuclear medicine and biology 1996;23(7):917-22.
1996: Rusckowski M; Paganelli G; Hnatowich D J; Magnani P; Virzi F; Fogarasi M; DiLeo C; Sudati F; Fazio F
Imaging osteomyelitis with streptavidin and indium-111-labeled biotin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(10):1655-62.
1996: Winnard P; Virzi E; Fogarasi M; Rusckowski M; Hnatowich D J
Investigations of directly labeling antibodies with rhenium-188.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1996;40(2):151-60.
1996: Hnatowich D J; Mardirossian G; Rusckowski M; Winnard P
Protein labelling via deoxyribonucleic acid hybridization.
Nuclear medicine communications 1996;17(1):66-75.
1996: Hnatowich D J; Mardirossian G; Fogarasi M; Sano T; Smith C L; Cantor C R; Rusckowski M; Winnard P
Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice.
The Journal of pharmacology and experimental therapeutics 1996;276(1):326-34.
1995: Hnatowich D J; Winnard P; Virzi F; Fogarasi M; Sano T; Smith C L; Cantor C R; Rusckowski M
Technetium-99m labeling of DNA oligonucleotides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2306-14.
1995: Virzi F; Winnard P; Fogarasi M; Sano T; Smith C L; Cantor C R; Rusckowski M; Hnatowich D J
Recombinant metallothionein-conjugated streptavidin labeled with 188Re and 99mTc.
Bioconjugate chemistry 1995;6(1):139-44.
1995: Rusckowski M; Fogarasi M; Virzi F; Hnatowich D J
Influence of endogenous biotin on the biodistribution of labelled biotin derivatives in mice.
Nuclear medicine communications 1995;16(1):38-46.
1994: Hnatowich D J; Virzi F; Fogarasi M; Rusckowski M; Winnard P
Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?
Nuclear medicine and biology 1994;21(8):1035-44.
1994: Hnatowich D J; Virzi F; Winnard P; Fogarasi M; Rusckowski M
Investigations of ascorbate for direct labeling of antibodies with technetium-99m.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(1):127-34.
1993: Hnatowich D J; Fritz B; Virzi F; Mardirossian G; Rusckowski M
Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody.
Nuclear medicine and biology 1993;20(2):189-95.
1993: Hnatowich D J; Mardirossian G; Rusckowski M; Roy S; Bushe H; Griffin T W; Brill A B
Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients.
Nuclear medicine communications 1993;14(1):52-63.
1993: Hnatowich D J; Mardirossian G; Rusckowski M; Fogarasi M; Virzi F; Winnard P
Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo properties.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(1):109-19.
1992: Rusckowski M; Fritz B; Hnatowich D J
Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(10):1810-5.
1992: Mardirossian G; Wu C; Rusckowski M; Hnatowich D J
The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.
Nuclear medicine communications 1992;13(7):503-12.
1992: Hnatowich D J; Rusckowski M; Siebecker D A; Gionet M; Mardirossian G; Bushe H S; Roy S; Mattis J A; Shealy D; Griffin T W
Pharmacokinetics of indium-111 labeled 10-3D2 antibreast-tumor antibody in patients.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1992;36(1):7-13.
1991: Griffin T W; Brill A B; Stevens S; Collins J A; Bokhari F; Bushe H; Stochl M C; Gionet M; Rusckowski M; Stroupe S D
Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):631-40.
1991: Virzi F; Fritz B; Rusckowski M; Gionet M; Misra H; Hnatowich D J
New indium-111 labeled biotin derivatives for improved immunotargeting.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(7):719-26.
1990: Kalofonos H P; Rusckowski M; Siebecker D A; Sivolapenko G B; Snook D; Lavender J P; Epenetos A A; Hnatowich D J
Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(11):1791-6.
1990: Hnatowich D J; Rusckowski M; Brill A B; Siebecker D A; Misra H; Mardirossian G; Bushe H; Rescigno A; Stevens S; Johnson D K
Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.
Cancer research 1990;50(22):7272-8.
1990: Rescigno A; Bushe H; Brill A B; Rusckowski M; Griffin T W; Hnatowich D J
Pharmacokinetic modeling of radiolabeled antibody distribution in man.
American journal of physiologic imaging 1990;5(4):141-50.
1987: Hnatowich D J; Gionet M; Rusckowski M; Siebecker D A; Roche J; Shealy D; Mattis J A; Wilson J; McGann J; Hunter R E
Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody.
Cancer research 1987;47(22):6111-7.
1987: Hnatowich D J; Virzi F; Rusckowski M
Investigations of avidin and biotin for imaging applications.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(8):1294-302.
1985: Hnatowich D J; Griffin T W; Kosciuczyk C; Rusckowski M; Childs R L; Mattis J A; Shealy D; Doherty P W
Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(8):849-58.
1985: Rusckowski M; Doherty P W; Virzi F; Hnatowich D J
A simple in vitro method of screening panels of monoclonal antibodies for tumor binding.
Journal of immunological methods 1985;76(2):375-82.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Mary Rusckowski

Research Profile (preview)

Living Beings

Concepts & Ideas

Chemicals & Drugs

Procedures

Anatomy

Phenomena

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Mary Rusckowski (preview)

All Publications